Europe
The EU’s health nominee may not be as controversial as the recent US one, but the candidate being grilled has proved the least popular of the commissioner nominations with MEPs
OTC antifungal fluconazole will soon only be available with a doctor's prescription in Norway.
Over five years, the cost of the European Commission's proposal could exceed a total €50bn, finds a study by IQVIA commissioned by the AESGP.
Finland is the latest market launch for OTC erectile dysfunction treatment Eroxon. High demand for the product in other countries, such as Norway, helped drive up Navamedic's consumer health sales in the first nine months of 2024.
Consumers in Denmark no longer need a prescription to buy opioid antagonist naloxone as the country looks to tackle the growing issue of overdose.
A round-up of recent consumer health appointments: PharmaSGP names new CEO; Stada appoints Vietnam head; NèreS adds to board.
Stada will ship a wide range of consumer healthcare products from its new Romanian production facility, into which the German firm has invested over €70m.
Focusing on the transitional elements of hormone health, marketing dietary supplements to women going through perimenopause and menopause, Health & Her has been acquired by UK-based Venture Life.
Bayer Consumer Health is replacing mixed material PVC blister packs with monomaterial PET blisters beginning with Aleve in the Netherlands. HBW Insight speaks to vice president and global head of design, packaging, product experience and sustainability, Chris Padain, about the "evolutionary" strategy behind the move, the complexities of choosing the right material for the right product, and the importance of industry cross-collaboration via associations like GSCF.
Dietary supplement ingredient promising enhanced memory and mental clarity marketed widely across the US has been authorized for sale in Europe.
Perrigo is among the supporters of a campaign to get a clause of Germany's Medicines Advertising Act removed, which bans the advertising of the OTC morning after pill.
EFSA has published new guidance to assist companies navigating the EU’s novel food authorisation process. HBW Insight speaks to experts Dr Mari Eskola of Medfiles and Dr Jérôme Le Bloch of FoodChain ID who offer differing views on the benefits and drawbacks of the guidance for industry.
A better than expected showing from its Health business in its latest quarter has teed up Reckitt for a big finish to the year.
Even at conservative estimates, switching an additional 97 molecules could save about €200m, according to France's consumer health industry association.
“Politicians must create the right framework” to promote Rx-to-OTC switch in Germany, insists Pharma Deutschland deputy general manager Elmar Kroth.
After coming under fire from French politicians and workers unions over its proposal to sell a majority stake in its consumer health business to US private-equity firm CD&R, Sanofi has invited the French state in on the deal and made a number of binding commitments to jobs and investment.
Major Europe-based consumer health players Sanofi, Haleon, Reckitt and Bayer feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q3 2024 results over the coming weeks.
Qnovia notes NRT inhalation product recently received investigational new drug clearance from FDA as agency and NIH say innovation needed smoking cessation to help improve rate of success for quitting the habit that kills around 500,000 US consumers annually.
Control of Sanofi Consumer Healthcare – recently rebranded as Opella – may soon pass to US private-equity firm CD&R but the French firm looks set to retain a substantial stake in a business which has some big Rx-to-OTC switches in the pipeline.
Bayer adds dry eye treatment to its Bepanthen skin care range; Stada launches special edition Elotrans supplement for Eintracht Frankfurt fans; Hermes offers chewable magnesium supplement; and Klosterfrau introduces Oyono Night extension to help troubled sleepers maintain their immunity.